Alyeska Investment Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-237,862
Closed -$22.7M 627
2025
Q4
$22.7M Buy
+237,862
New +$23.3M 0.06% 300
2025
Q2
Sell
-1,202,779
Closed -$121M 573
2025
Q1
$121M Sell
1,202,779
-438,655
-27% -$44.2M 0.48% 56
2024
Q4
$147M Buy
1,641,434
+1,271,434
+344% +$112M 0.55% 34
2024
Q3
$31M Sell
370,000
-92,803
-20% -$7.32M 0.16% 191
2024
Q2
$35.6M Sell
462,803
-1,159,646
-71% -$84.9M 0.2% 140
2024
Q1
$111M Sell
1,622,449
-738,912
-31% -$47.5M 0.68% 35
2023
Q4
$137M Buy
2,361,361
+201,428
+9% +$10.8M 0.9% 20
2023
Q3
$114M Buy
2,159,933
+1,459,933
+209% +$76.6M 0.77% 24
2023
Q2
$37.9M Buy
+700,000
New +$36.6M 0.28% 119
2021
Q1
Sell
-42,040
Closed -$1.51M 742
2020
Q4
$1.51M Buy
+42,040
New +$1.52M 0.02% 392
2019
Q3
Sell
-27,357
Closed -$1.18M 417
2019
Q2
$1.18M Buy
+27,357
New +$1.05M 0.02% 359
2017
Q2
Sell
-210,199
Closed -$5.23M 459
2017
Q1
$5.23M Sell
210,199
-2,275,001
-92% -$55.3M 0.04% 310
2016
Q4
$53.8M Buy
+2,485,200
New +$54.2M 0.44% 71

Other funds holding BSX

Alyeska Investment Group's BSX Position: Q1 2026 in Review

Alyeska Investment Group sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 237,862 shares — an estimated $22.7M sold.

Alyeska Investment Group first reported a position in BSX in Q4 2016 and held it in 13 quarters. The position peaked at $147M in Q4 2024. 1,681 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Alyeska Investment Group reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 237,862 Boston Scientific shares in Q1 2026, an estimated $22.7M.
  • Alyeska Investment Group first reported a position in Boston Scientific in Q4 2016 and held it in 13 quarters.
  • Alyeska Investment Group's Boston Scientific position peaked at $147M in Q4 2024.
  • 1,681 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.